ArticleCancer research and treatment2023

Long-term Complete Remission of Decitabine-Primed Tandem CD19/CD22 CAR-T Therapy with PD-1 and BTK Inhibitors Maintenance in a Refractory Primary Central Nervous System Lymphoma Patient.

Rui Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.